α-Glucosidase Inhibitory, Aromatase Inhibitory, and Antiplasmodial Activities of a Biflavonoid GB1 from Garcinia kola Stem Bark

Abstract

The biflavonoid, 3′′,4′,4′′′,5,5′′,7,7′′-heptahydroxy-3,8-biflavanone, known as GB1 (1), was isolated as a major constituent from Garcinia kola stem bark. GB1 (1) exhibited α-glucosidase and aromatase inhibitory activities, as well as antiplasmodial activity, but was not toxic against cell lines tested. GB1 (1) may be a potential dietary supplement or phytomedicine for the prevention of breast cancer and type 2 diabetes mellitus.

Garcinia kola - Guttiferae - α‐glucosidase inhibitor - aromatase inhibitor - antiplasmodial - biflavonoid

References

• 1 Iwu M M, Igboko O. Flavonoids of Garcinia kola seeds.  J Nat Prod. 1982;  45 650-651
• 2 Okunji C O, Ware T A, Hicks R P, Iwu M M, Skanchy D J. Capillary electrophoresis determination of biflavanones from Garcinia kola in three traditional African medicinal formulations.  Planta Med. 2002;  68 440-444
• 3 Hussain R A, Owegby A G, Parimoo P, Waterman P G. Kolanone, a novel polyisoprenylated benzophenone with antimicrobial properties from the fruit of Garcinia kola.  Planta Med. 1982;  44 78-81
• 4 Han Q B, Lee S F, Qiao C F, He Z D, Song J Z, Sun H D, Xu H X. Complete NMR assignments of the antibacterial biflavonoid GB1 from Garcinia kola.  Chem Pharm Bull. 2005;  53 1034-1036
• 5 Adaramoye O A, Medeiros I A. Endothelium-independent vasodilation induced by kolaviron, a biflavonoid complex from Garcinia kola seeds, in rat superior mesenteric arteries.  J Smooth Muscle Res. 2009;  45 39-53
• 6 Farombi E O, Shrotriya S, Surh Y J. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1.  Life Sci. 2009;  84 149-155
• 7 Okunji C, Komarnytsky S, Fear G, Poulev A, Ribnicky D M, Awachie P I, Ito Y, Raskin I. Preparative isolation and identification of tyrosinase inhibitors from the seeds of Garcinia kola by high-speed counter-current chromatography.  J Chromatogr A. 2007;  1151 45-50
• 8 Adaramoye O A, Adeyemi E O. Hepatoprotection of D-galactosamine-induced toxicity in mice by purified fractions from Garcinia kola seeds.  Basic Clin Pharmacol Toxicol. 2006;  98 135-141
• 9 Adaramoye O A, Adeyemi E O. Hypoglycaemic and hypolipidaemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia kola in streptozotocin-induced diabetes mellitus rats.  J Pharm Pharmacol. 2006;  58 121-128
• 10 Farombi E O, Nwaokeafor I A. Anti-oxidant mechanisms of kolaviron: studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats.  Clin Exp Pharmacol Physiol. 2005;  32 667-674
• 11 Terashima K, Takaya Y, Niwa M. Powerful antioxidative agents based on garcinoic acid from Garcinia kola.  Bioorg Med Chem. 2002;  10 1619-1625
• 12 Farombi E O, Adepoju B F, Ola-Davies O E, Emerole G O. Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural bioflavonoid of Garcinia kola seeds.  Eur J Cancer Prev. 2005;  14 207-214
• 13 Adaramoye O A, Nwaneri V O, Anyanwu K C, Farombi E O, Emerole G O. Possible anti-atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats.  Clin Exp Pharmacol Physiol. 2005;  32 40-46
• 14 Tona L, Cimanga R K, Mesia K, Musuamba C T, De Bruyne T, Apers S, Hernans N, Van Miert S, Pieters L, Totté J, Vlietinck A J. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo.  J Ethnopharmacol. 2004;  93 27-32
• 15 Braide V B. Antiinflammatory effect of kolaviron, a biflavonoid extract of Garcinia kola.  Fitoterapia. 1993;  64 433-439
• 16 Gescher A, Gerhäuser C. Cancer chemopreventive agents in plants – a continuing challenge.  Planta Med. 2008;  74 1523-1525
• 17 Francy-Guilford J, Pezzuto J M. Mechanisms of cancer chemopreventive agents: a perspective.  Planta Med. 2008;  74 1644-1650
• 18 Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic.  Nature. 2001;  414 782-787
• 19 Paoletta S, Steventon G B, Wildeboer D, Ehrman T M, Hylands P J, Barlow D J. Screening of herbal constituents for aromatase inhibitory activity.  Bioorg Med Chem. 2008;  16 8466-8470
• 20 Eng E T, Ye J, Williams D, Phung S, Moore R E, Young M K, Gruntmanis U, Braunstein G, Chen S. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds.  Cancer Res. 2003;  63 8516-8522
• 21 Cuzick J. Aromatase inhibitors for breast cancer prevention.  J Clin Oncol. 2005;  23 1636-1643
• 22 Iwu M M, Igboko O A, Okunji C O, Tempesta M S. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola.  J Pharm Pharmacol. 1990;  42 290-292
• 23 Tabopda T K, Ngoupayo J, Awoussong P K, Mitaine-Offer A C, Ali M S, Ngadjui B T, Lacaille-Dubois M A. Triprenylated flavonoids from Dorstenia psilurus and their alpha-glucosidase inhibition properties.  J Nat Prod. 2008;  71 2068-2072
• 24 Lee S S, Lin H C, Chen C K. Acylated flavonol monorhamnosides, alpha-glucosidase inhibitors, from Machilus philippinensis.  Phytochemistry. 2008;  69 2347-2353
• 25 Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.  Lancet. 2009;  373 1607-1614